SCHEMBL1090288

SCHEMBL1090288

COc1cccc(C(=O)N2CCC(N3CCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 3/20 0.49
NOS1 P29475 3/20 0.48
NOS2 P35228 3/20 0.48
NOS3 P29474 2/20 0.48
HPGD P15428 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
CXCR4 P61073 1/20 0.45
TSHR P16473 2/20 0.45
KMT2A Q03164 2/20 0.45
GFER P55789 1/20 0.45
LMNA P02545 1/20 0.45
ABL1 P00519 2/20 0.45
BCR P11274 2/20 0.45
CCNK O75909 1/20 0.44
CDK12 Q9NYV4 1/20 0.44
MEN1 O00255 1/20 0.44
SYK P43405 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090683 0.96 ALDH1A1 (0.48) ALDH1A1KDM4ENOS1NOS2NOS3
SCHEMBL1090445 0.96 ALDH1A1 (0.50) ALDH1A1KDM4ENOS1NOS2NOS3
SCHEMBL1091235 0.92 GFER (0.49) ALDH1A1NOS1NOS2NOS3HPGD
SCHEMBL1089141 0.90 CDK12 (0.48) ALDH1A1KDM4ENOS1NOS2NOS3
SCHEMBL1090983 0.90 GBA1 (0.49) KDM4EHPGDCXCR4KMT2ACCNK
SCHEMBL1090714 0.89 GFER (0.51) ALDH1A1HPGDCCNCCDK8KMT2A
SCHEMBL1091454 0.88 GFER (0.51) ALDH1A1HPGDCCNCCDK8KMT2A
SCHEMBL1090198 0.88 MEN1 (0.52) ALDH1A1KDM4ECXCR4KMT2ACCNK
SCHEMBL1089294 0.88 TDP1 (0.54) ALDH1A1KDM4EHPGDCXCR4TSHR
SCHEMBL1091044 0.87 CXCR4 (0.56) ALDH1A1KDM4ENOS1NOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885NOS1 171/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885NOS1 171/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885NOS1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.